Phaenora Laboratories
Advancing healthcare while keeping it close to everyday life.
Phaenora brings fundamental research, pharmaceutical manufacturing and clinical support together around a shared commitment: making scientific advances accessible to as many people as possible.
The Director
Gabrielle Keller
Chief Executive Officer
“A healthcare company is measured by what it brings to the generations that follow.”
Gabrielle Keller has shaped Phaenora into a group capable of connecting essential medicines with the most advanced research. She promotes a demanding vision of scientific responsibility, founded on knowledge sharing, care for families and long-term commitment.
Key milestones
A history built between industry and research.
- 1970
Creation of the family laboratory the group grew from.
- 2005
Acquisition of the assets of an oceanographic research institute.
- 2008
Creation of a cross-functional life sciences division.
- 2012
Expansion of oceanographic research capabilities with NS003.
- 2022
Launch of a new integrated research strategy.
- Today
Development of the Anabasis Programme and new cohorts.
“What we do today will allow future generations to live in a better world.”